Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanofi (SNYNF)
OTHER OTC:SNYNF
Sanofi (SNYNF) Stock Price & Analysis
330 Followers
SNYNF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$86.12 - $115.25
Previous Close$92.7
Volume600.73K
Average Volume (3M)38.65K
Market Cap
$113.72B
Enterprise Value$123.47B
Total Cash (Recent Filing)$8.71B
Total Debt (Recent Filing)$18.15B
Price to Earnings (P/E)19.9
Beta0.25
Next Earnings
Apr 25, 2024EPS Estimate
$1.83Next Dividend Ex-Date
May 13, 2024Dividend Yield3.89%
Share Statistics
EPS (TTM)4.67
Shares Outstanding1,252,640,466
10 Day Avg. Volume7,745
30 Day Avg. Volume38,650
Standard Deviation0.06
R-Squared0.07
Alpha0.00353
Financial Highlights & Ratios
Price to Book (P/B)40.36
Price to Sales (P/S)2.52
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.17
Enterprise Value/Gross Profit3.83
Enterprise Value/Ebitda23.96
Forecast
1Y Price Target
$105.01Price Target Upside13.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Sanofi News
Bulls Say, Bears Say
Bulls Say
Drug DevelopmentTolebrutinib is seen as having key advantages over competitors due to better pharmacology and positive biomarker data suggestive of progression benefit.
Financial OutlookAnalyst maintains a 'Buy' rating with a price objective of 122.00 EUR, suggesting a significant upside from the current price of 86.55 EUR.
Legal And Financial ResolutionsSanofi has settled the majority of state-based Zantac litigation, which is expected to have no material financial impact.
Bears Say
Earnings Guidance2024 EPS guidance approximately 5% below consensus.
Financial PerformanceAnalyst reduced the 1Q24E revenue forecast from €11.1B to €11.0B.
Legal RisksA decision is pending in litigation in Delaware where over 70k claims are filed, with Sanofi being named in 20k of them.
---
Ownership Overview
0.00%
Insiders
12.83% Mutual Funds
12.42% Other Institutional Investors
74.75% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
SNYNF FAQ
What was Sanofi’s price range in the past 12 months?
Sanofi lowest stock price was $86.12 and its highest was $115.25 in the past 12 months.
What is Sanofi’s market cap?
Currently, no data Available
When is Sanofi’s upcoming earnings report date?
Sanofi’s upcoming earnings report date is Apr 25, 2024 which is in 6 days.
How were Sanofi’s earnings last quarter?
Sanofi released its earnings results on Feb 01, 2024. The company reported $1.762 earnings per share for the quarter, missing the consensus estimate of $1.835 by -$0.072.
Is Sanofi overvalued?
According to Wall Street analysts Sanofi’s price is currently Undervalued.
Does Sanofi pay dividends?
Sanofi pays a Annually dividend of $3.99 which represents an annual dividend yield of 3.89%. See more information on Sanofi dividends here
What is Sanofi’s EPS estimate?
Sanofi’s EPS estimate is $1.83.
How many shares outstanding does Sanofi have?
Sanofi has 1,264,797,500 shares outstanding.
What happened to Sanofi’s price movement after its last earnings report?
Sanofi reported an EPS of $1.762 in its last earnings report, missing expectations of $1.835. Following the earnings report the stock price went down -4.366%.
Which hedge fund is a major shareholder of Sanofi?
Currently, no hedge funds are holding shares in SNYNF
---
Sanofi Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$105.01 (13.28% Upside)
$105.01 (13.28% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-15.72%
12-Months-Change
Fundamentals
Return on Equity
7.22%
Trailing 12-Months
Asset Growth
3.29%
Trailing 12-Months
Company Description
Sanofi
Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities. This segment also includes all associates whose activities are related to pharmaceuticals. The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for its Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines. The company was founded in 1973 and is headquartered in Paris, France.
---
SNYNF Company Deck
---
SNYNF Earnings Call
Q4 2024
0:00 / 0:00
---
SNYNF Stock 12 Months Forecast
Average Price Target
$105.01
▲(13.28% Upside)
Technical Analysis
Best Analysts Covering SNYNF
1 Year
1 Year Success Rate
14/18 ratings generated profit
1 Year Average Return
+5.03%
reiterated a buy rating 9 months ago
Copying Dominic Lunn's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +5.03% per trade.
---